Why the study?
Do various pharmaceutical agents improve mortality and morbidity in patients with congestive heart failure and left ventricular dysfunction?
Do various pharmaceutical agents improve mortality and morbidity in patients with congestive heart failure and left ventricular dysfunction?
Answers are grounded in this paper and cite their sources.
This review highlights the proven mortality benefits of ACE inhibitors in heart failure while warning against the harmful effects of phosphodiesterase inhibitors, beta agonists, class I antiarrhythmics, and calcium channel blockers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Salim Yusuf (1993) conducted a review in Congestive heart failure and left ventricular dysfunction. Pharmaceutical agents (ACE inhibitors, digoxin, antiarrhythmics) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: